Larry Ellison Cancels Plan To Sell Oracle Stock
Larry Ellison cancels plan to sell Oracle stock; Oracle said no shares were sold, removing an immediate insider-selling overhang for investors.

KEY TAKEAWAYS
- Ellison canceled his Rule 10b5-1 plan and Oracle said no shares were sold under it.
- A regulatory filing had shown adoption on June 22 authorizing up to 50 million shares.
- The cancellation removes an immediate insider-selling overhang for investors.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Oracle said in a press release on Sept. 12, 2026, that Larry Ellison canceled a plan to sell Oracle stock. The company confirmed no shares were sold under the Rule 10b5‑1 trading arrangement and that Ellison has no other plans to sell his Oracle shares, easing investor concern about a large insider sale.
Ellison Cancels 10b5‑1 Plan
Larry Ellison, Oracle’s Executive Chair of the Board and Chief Technology Officer, canceled his Rule 10b5‑1 plan to sell Oracle stock, the company said. The release stated no shares were sold under the plan and Ellison has no other plans to sell his holdings. Oracle’s brief statement focused on these points without further explanation. [source:1]
Plan Parameters and SEC Filing
A regulatory filing published on Sept. 11, 2026, disclosed that Ellison adopted the Rule 10b5‑1 trading plan on June 22, 2026. The plan authorized potential sales of up to 50 million Oracle shares, valued at about $7.5 billion at contemporaneous prices, and set a scheduled end date of Oct. 24, 2026. [source:10][source:11]
Rule 10b5‑1 plans are prearranged trading programs that allow insiders to sell shares according to a preset schedule. They aim to protect insiders from allegations of trading on material nonpublic information if the plan is established in good faith.
Investor Context and Implications
Ellison has historically sold only modest volumes of Oracle stock, with reports noting he has not sold more than 25,000 shares at a time this century. The newly disclosed plan’s authorization to sell up to 50 million shares was unusually large compared with his past behavior.
The cancellation removes the immediate prospect of a large scheduled insider sale, easing the near-term overhang that had drawn investor attention.





